SCHEMBL4983271

SCHEMBL4983271

CS(=O)(=O)OCC1CNCCN1C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
CA1 P00915 4/20 0.37
CA2 P00918 4/20 0.37
CA4 P22748 4/20 0.37
CA9 Q16790 4/20 0.37
ADRB1 P08588 1/20 0.34
CHRNA7 P36544 2/20 0.34
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28003047 0.83 CHRNA7 (0.38) CHRNA7KCNH2
SCHEMBL25409001 0.83 CHRNA7 (0.38) CHRNA7KCNH2
SCHEMBL3196435 0.83 CHRNA7 (0.38) CHRNA7KCNH2
SCHEMBL30879748 0.82 PARP1 (0.49) CA1CA2CA4CA9
SCHEMBL29947951 0.81 CA1 (0.38) CA1CA2CA4CA9ADRB1
SCHEMBL2570483 0.79 TP53 (0.32)
SCHEMBL2570484 0.79 TP53 (0.32)
SCHEMBL18689125 0.79 TP53 (0.32)
SCHEMBL24357910 0.78 HTR2C (0.49) CA1CA2CA4CA9
SCHEMBL4678845 0.77 CA1 (0.36) CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2941432-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE Vertex Pharmaceuticals Inc. (US) 2015-11-11 EP disclosed
WO-2014089379-A9 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-01-15 WO disclosed
WO-2014089379-A1 COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-06-12 WO disclosed
EP-1984355-A2 CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION Takeda Pharmaceutical Company Limited (JP) 2008-10-29 EP disclosed
WO-2007094513-A2 CYCLIC AMINE COMPOUND AND USE THEREOF FOR THE PROPHYLAXIS OR TREATMENT OF HYPERTENSION TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-08-23 WO disclosed